Kathy Bates, 76, displays her incredible 100Ib weight loss at CBS curtain-raiser after revealing the moment that sparked her Ozempic journey
The article discusses the rising popularity of semaglutide, branded as Ozempic, a drug originally developed for type 2 diabetes but now used off-label for weight loss. Celebrities and influencers have contributed to its demand, leading to shortages. The drug, produced by Novo Nordisk, has shown significant weight loss results but comes with side effects and is not effective for everyone. Experts emphasize the importance of lifestyle changes alongside medication. The article highlights the ethical concerns of using such drugs for weight loss and the potential for broader approval in the future.

Haber tarzıDengeli
Balanced discussion on the benefits and concerns of using semaglutide for weight loss.



